ADL and CONUT for Predicting 1-year Mortality Risk in Older Adults After Hip Fracture

All-cause Mortality Clinical Trial

Official title:

Beijing Tongren Hospital, Capital Medical University

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05814172
• Other study ID #: TREC2023-KY026
• Status: Recruiting
• Start date: October 2023
• Est. completion date: November 2023

Study information

• Verified date: March 2023
• Source: Beijing Tongren Hospital
• Contact: YING CHEN
• Phone: 008613621247560
• Email: trchenying[@]mail.ccmu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Hip fracture has a serious impact on the quality of life and even the survival of older adults. The multidisciplinary management of hip fracture has been shown to be effective in improving patient outcome and cost-effective in international studies. As geriatricians and members of a multi-disciplinary team（MDT）, we are aware of various scores in predicting the 1-year mortality risk in hospitalized older adults with multimorbidity. However, given the need for a deeper understanding of the preoperative status of elderly patients who were suffering from pain, tension, anxiety, delirium,etc., we hope to explore a simple, quick, objective, and accurate method for assessing the status of elderly patients with hip fractures to predict their survival risk.

Description:

This was a single-center retrospective cohort study which were approved by the Clinical Research Ethics Committee of Beijing Tongren Hospital, Capital Medical University (TREC2023-KY026). Demographic characteristics and medical parameters, such as age, gender, body mass index (BMI), comorbidities, hemoglobin , lymphocytes, C-reactive protein (CRP), fasting blood glucose, creatinine, total protein, albumin, triglycerides, total cholesterol and American Association of Anesthesiologists (ASA) were collected from the electronic medical record system. Controlling nutritional status (CONUT) was calculated from 3 variables: serum albumin concentration, total cholesterol concentration, and lymphocyte count, as previously reported. All enrolled patients were followed-up in an outpatients setting. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. The follow-up lasted for one year and the last follow-up was ended on December 31, 2022. All analyses were performed using SPSS version 19.0 (SPSS, Chicago, IL, USA).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 303
• Est. completion date: November 2023
• Est. primary completion date: November 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years to 110 Years

Eligibility

Inclusion Criteria:

1. patients aged ?65 years old;

2. patients diagnosed with hip fracture, including femoral neck fracture, femoral intertrochanteric fracture, and femoral subtrochanteric fracture;

3. patients whose injury was within 21 days of presentation.

Exclusion Criteria:

1. patients aged <65 years old;

2. patients with pathological fractures due to tumor metastasis or infection or inherited bone disorder;

3. patients with avascular necrosis of femoral head;

4. patients with periprosthetic fractures;

5. old fracture patients treated more than 21 days from injury;

6. patients with severe trauma or fracture in other parts;

7. patients and their families who could not bear the surgical risk and are unwilling to receive surgical treatment;

8. patients died in hospital.

Related Conditions & MeSH terms

• All-cause Mortality

Intervention

Other:
• no intervention
no intervention

Locations

Country	Name	City	State
China	Beijing Tongren Hospital, Capital Medical University	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Beijing Tongren Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality	After discharge, all enrolled patients were followed-up in an outpatients setting. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. Survival data were obtained via direct contact with patients or patients' caregiver by their physicians at the hospital , or via telephone interview of their family by dedicated coordinators and investigators. Outcomes were recorded.	Calculated from the time of discharge, each patient was followed up 1 year, all-cause death in 1 year after discharge was counted.